Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)N. Costedoat‐Chalumeau, Alain Dupuy, Amar Smaïl et al.|Annals of the Rheumatic Diseases|2012Cited by 207
Risk factors for hydroxychloroquine retinopathy in systemic lupus erythematosus: a case–control study with hydroxychloroquine blood-level analysisTiphaine Lenfant, Olivier Fain, Gaëlle Leroux et al.|Lara D. Veeken|2020Cited by 51
Maladie de Castleman chez les patients infectés par le VIHLaurent Aaron, B. Dupont, Olivier Lidove et al.|La Revue de Médecine Interne|2002Cited by 13